A Case of SUNCT Syndrome Responsive to Verapamil
| Autor: | M. C. Narbone, M. Abbate, S. Gangemi |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Brain Infarction
Male Topiramate Pituitary gland medicine.medical_specialty Gabapentin Vasodilator Agents Lamotrigine Lesion 03 medical and health sciences 0302 clinical medicine Cerebellum medicine Humans 030212 general & internal medicine business.industry Headache General Medicine Middle Aged Dermatology medicine.anatomical_structure Verapamil International Classification of Headache Disorders Neurology (clinical) Headaches medicine.symptom business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Cephalalgia. 25:476-478 |
| ISSN: | 1468-2982 0333-1024 |
| DOI: | 10.1111/j.1468-2982.2004.00876.x |
| Popis: | SUNCT is a rare headache disorder, first described by Sjaastad et al. in 1989 (1) and recently codified by the International Classification of Headache Disorders as a primary headache (2). The literature, however, discloses some cases of secondary SUNCT syndrome, particularly due to lesions in the posterior fossa or involving the pituitary gland (3–10). The pharmacological treatment of this syndrome is problematic. Some encouraging results have been recently suggested with lamotrigine (11–15), gabapentin (16, 17) and topiramate (18, 19); all previous attempts at treatment with drugs used for other short-lasting headaches were unsuccessful (20). It is noteworthy that two reports (21, 22) even reported a worsening effect of verapamil in patients affected by SUNCT. We describe a patient with SUNCT syndrome and an ischaemic lesion in the posterior fossa, who was successfully treated with verapamil. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|